@techcrunch.com 1 month ago
How Cerebral and Alto Neuroscience embarked on an at-home clinical trial for depression
@sonu_monika 1 month ago
How medical device companies can benefit from #digitaltherapeutics https://j.mp/3244H5B @MedTechDaily #Data #BigData #ML #AI #NLP #Flutter #serverless #DataScience #RStats #IoT #IIoT #Analytics #DigitalHealth #EHR #EMR #publichealth #telehealth #biotech #pharma @sonu_monika
@tech.eu 2 months ago
Pharmaceutical giant Sanofi invests $180 million in French medical research platform Owkin
@techcrunch.com 2 months ago
Flagship Pioneering’s new venture is betting on tRNA to treat “thousands of diseases”
@techcrunch.com 3 months ago
Kiwi Bio aims to free irritable bowel syndrome sufferers from restrictive diets
@techcrunch.com 3 months ago
GraphWear closes $20.5M Series B for a needle-free, nanotech-powered glucose monitor
@techcrunch.com 4 months ago
Federated Genomic data startup Lifebit raises $60M round led by Tiger Global
@techcrunch.com 4 months ago
Alpha Medical closes $24M Series B round to expand women’s telehealth – without the video calls
@techcrunch.com 4 months ago
How Colossal sold investors on a quest to resurrect a woolly mammoth
@tech.eu 4 months ago
Why biotech investors are attracted to Lithuania
@ingliguori 5 months ago
AI-powered tools enable longevity medicine. Article from @Nature https://bit.ly/3tTIhO0 Via @ingliguori #biotech #machinelearning #healthtech #healthcareinnovation #medtech #healthtechnology #artificialintelligence #science #research @pierrepinna @mvollmer1 @antgrasso @AkwyZ https://t.co/l4ZrR4uMMO
@techcrunch.com 5 months ago
Rani Therapeutics’ $73M IPO will fund upcoming clinical trials
@techcrunch.com 6 months ago
Biofourmis receives FDA breakthrough device designation for heart failure “digital therapy”
@techcrunch.com 6 months ago
A magnetic helmet shrunk a deadly tumor in world-first test
@envedabio 6 months ago
Today @wolfejosh appeared on Bloomberg @business @Quicktake & shared how we are turning nature into medicines along with what’s next for #investors in emerging technologies #biotech #drugdiscovery #AI #MachineLearning https://bloom.bg/3B7hj90
@techcrunch.com 8 months ago
‘It’s almost like placing an IV’: Brain monitoring electrode receives FDA 510(k) clearance
@AWSstartups 8 months ago
#Healthcare & life sciences #startups, join us next Thursday to find out how @MissionBio, @InSilicoMeds, and @aizon_ai_ use cloud tech to power precision medicine and personalize patient journeys.⏰ Register now: https://go.aws/2RrMwl1 #healthtech #biotech #machinelearning #ai https://t.co/Nl4uJTcM40
@andresvilarino 9 months ago
#ArtificialIntelligence, like #Algorithms, could crack the language of #cancer & #Alzheimer’s, study finds #AI #HealthCare #HealthTech #DigitalHealth #MedicalTech #MedTech #BioTech #ML #MachineLearning #data https://buff.ly/3mFeCos https://t.co/lvl2otB2Du
@techcrunch.com 10 months ago
Vibrant raises $7.5M for a drug-free mechanical pill to treat constipation
@techcrunch.com 10 months ago
Y Combinator’s biotech startups incubate a new generation of therapies and tools
@_M_Dey 10 months ago
Digital twins could lead to more proactive, personalized medicine, researchers say | #HealthCare #DataScience #LifeSciences #DigitalTwin #PersonalizedMedicine #BioTech #MedTech #MachineLearning https://bit.ly/2OiLzKN
@Primary_Immune 1 year ago
🧬 A nice update on gene therapy '2.0' ...like the ring of "genes as medicines" :-) https://www.nature.com/articles/s41467-020-19507-0 #openscience #datascience #bigdata #rstats #technology #biotech #itrtg #genomics #raredisease https://t.co/EMUZn1AXBO
@xconomy.com 1 year ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com 1 year ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com 1 year ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com 1 year ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com 1 year ago
Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity
@xconomy.com 1 year ago
Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity
@xconomy.com 1 year ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com 1 year ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com 1 year ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com 1 year ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com 1 year ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com 1 year ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com 1 year ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com 1 year ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com 1 year ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@tech.eu 1 year ago
Swiss medtech startup Bloom Diagnostics launches new testing system after €10 million Series B
@xconomy.com 1 year ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com 1 year ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com 1 year ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com 1 year ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@Joseph_Santoro 1 year ago
Japanese supercomputer finds 30 existing drugs potentially effective to treat #COVID-19! https://mainichi.jp/english/articles/20200704/p2a/00m/0na/010000c #Tech #BioTech #AI #MachineLearning #ML #DL #DeepLearning #Science #Data #DataScience #PublicHealth #Health #Medicine #MedicalScience #Coronavirus #COVID19
@xconomy.com 1 year ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com 1 year ago
FDA Official: New “Playbook” Needed for CMC Reviews of Gene Therapy Products
@xconomy.com 1 year ago
CereVasc Lands $44M for New Medical Device to Drain “Water on the Brain”
@tech.eu 1 year ago
Belgian startup BioStrand raises €2 million to disrupt genetic data analysis
@xconomy.com 1 year ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic